Trial Profile
The comparison of the efficacy of ezetimibe and fenofibrate versus atorvastatin alone in the lowering of LDL [low density lipoprotein] cholesterol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Fenofibrate (Primary) ; Atorvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2009 Actual end date (July 2006) added as reported by ClinicalTrials.gov.
- 07 Oct 2006 New trial record.